As of 2026-10-21, the Relative Valuation of Bioatla Inc (BCAB) is (521.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.74 USD, the upside of Bioatla Inc based on Relative Valuation is -30160.5%.
The range of the Relative Valuation is (485.07) - (535.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.6x - 28.3x | 27.5x |
| Forward P/E multiples | 25.0x - 28.4x | 27.6x |
| Fair Price | (485.07) - (535.48) | (521.55) |
| Upside | -28058.1% - -30963.2% | -30160.5% |
| Date | P/E |
| 2026-10-16 | -0.07 |
| 2026-10-15 | -0.07 |
| 2026-10-14 | -0.07 |
| 2026-10-13 | -0.07 |
| 2026-10-12 | -0.07 |
| 2026-10-09 | -0.08 |
| 2026-10-08 | -0.08 |
| 2026-10-07 | -0.08 |
| 2026-10-06 | -0.07 |
| 2026-10-05 | -0.07 |
| 2026-10-02 | -0.07 |
| 2026-10-01 | -0.07 |
| 2026-09-30 | -0.07 |
| 2026-09-29 | -0.07 |
| 2026-09-28 | -0.08 |
| 2026-09-25 | -0.08 |
| 2026-09-24 | -0.08 |
| 2026-09-23 | -0.08 |
| 2026-09-22 | -0.09 |
| 2026-09-21 | -0.10 |
| 2026-09-18 | -0.09 |
| 2026-09-17 | -0.10 |
| 2026-09-16 | -0.13 |
| 2026-09-15 | -0.07 |
| 2026-09-14 | -0.08 |
| 2026-09-11 | -0.08 |
| 2026-09-10 | -0.06 |
| 2026-09-09 | -0.06 |
| 2026-09-08 | -0.07 |
| 2026-09-04 | -0.07 |
| 2026-09-03 | -0.07 |
| 2026-09-02 | -0.06 |
| 2026-09-01 | -0.06 |
| 2026-08-31 | -0.09 |
| 2026-08-28 | -0.09 |
| 2026-08-27 | -0.17 |
| 2026-08-26 | -0.16 |
| 2026-08-25 | -0.17 |
| 2026-08-24 | -0.17 |
| 2026-08-21 | -0.17 |
| 2026-08-20 | -0.17 |
| 2026-08-19 | -0.17 |
| 2026-08-18 | -0.17 |
| 2026-08-17 | -0.16 |
| 2026-08-14 | -0.16 |
| 2026-08-13 | -0.18 |
| 2026-08-12 | -0.18 |
| 2026-08-11 | -0.18 |
| 2026-08-10 | -0.18 |
| 2026-08-07 | -0.18 |